- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Narcotics, also called opioids, are a necessary and important part of medical care. They include strong prescription pain relievers, such as oxycodone, hydrocodone, fentanyl, and tramadol. The illegal drug heroin is also an opioid. Some opioids are made from the opium plant, and others are synthetic (man-made).
According to our latest study, the global Narcotic (Opioid) Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Narcotic (Opioid) Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Narcotic (Opioid) Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Narcotic (Opioid) Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Narcotic (Opioid) Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Narcotic (Opioid) Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Narcotic (Opioid) Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Narcotic (Opioid) Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Teva, Purdue Pharma, Mallinckrodt and Amneal Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Narcotic (Opioid) Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Codeine
Fentanyl
Hydrocodone
Hydromorphone
Meperidine
Methadone
Others
Market segment by Application
Pain Relief Application
Anesthesia Application
Market segment by players, this report covers
Pfizer
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
Johnson & Johnson
Merck
Mylan
Hikma Pharmaceuticals
Sun Pharma
Endo Pharmaceuticals
Allergan
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Narcotic (Opioid) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Narcotic (Opioid) Drugs, with revenue, gross margin and global market share of Narcotic (Opioid) Drugs from 2018 to 2023.
Chapter 3, the Narcotic (Opioid) Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Narcotic (Opioid) Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Narcotic (Opioid) Drugs.
Chapter 13, to describe Narcotic (Opioid) Drugs research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Narcotic (Opioid) Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Narcotic (Opioid) Drugs by Type
1.3.1 Overview: Global Narcotic (Opioid) Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Narcotic (Opioid) Drugs Consumption Value Market Share by Type in 2022
1.3.3 Codeine
1.3.4 Fentanyl
1.3.5 Hydrocodone
1.3.6 Hydromorphone
1.3.7 Meperidine
1.3.8 Methadone
1.3.9 Others
1.4 Global Narcotic (Opioid) Drugs Market by Application
1.4.1 Overview: Global Narcotic (Opioid) Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pain Relief Application
1.4.3 Anesthesia Application
1.5 Global Narcotic (Opioid) Drugs Market Size & Forecast
1.6 Global Narcotic (Opioid) Drugs Market Size and Forecast by Region
1.6.1 Global Narcotic (Opioid) Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Narcotic (Opioid) Drugs Market Size by Region, (2018-2029)
1.6.3 North America Narcotic (Opioid) Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Narcotic (Opioid) Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Narcotic (Opioid) Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Narcotic (Opioid) Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Narcotic (Opioid) Drugs Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Narcotic (Opioid) Drugs Product and Solutions
2.1.4 Pfizer Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Narcotic (Opioid) Drugs Product and Solutions
2.2.4 Teva Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Recent Developments and Future Plans
2.3 Purdue Pharma
2.3.1 Purdue Pharma Details
2.3.2 Purdue Pharma Major Business
2.3.3 Purdue Pharma Narcotic (Opioid) Drugs Product and Solutions
2.3.4 Purdue Pharma Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Purdue Pharma Recent Developments and Future Plans
2.4 Mallinckrodt
2.4.1 Mallinckrodt Details
2.4.2 Mallinckrodt Major Business
2.4.3 Mallinckrodt Narcotic (Opioid) Drugs Product and Solutions
2.4.4 Mallinckrodt Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mallinckrodt Recent Developments and Future Plans
2.5 Amneal Pharma
2.5.1 Amneal Pharma Details
2.5.2 Amneal Pharma Major Business
2.5.3 Amneal Pharma Narcotic (Opioid) Drugs Product and Solutions
2.5.4 Amneal Pharma Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Amneal Pharma Recent Developments and Future Plans
2.6 Collegium
2.6.1 Collegium Details
2.6.2 Collegium Major Business
2.6.3 Collegium Narcotic (Opioid) Drugs Product and Solutions
2.6.4 Collegium Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Collegium Recent Developments and Future Plans
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Product and Solutions
2.7.4 Johnson & Johnson Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Johnson & Johnson Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Narcotic (Opioid) Drugs Product and Solutions
2.8.4 Merck Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Merck Recent Developments and Future Plans
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan Narcotic (Opioid) Drugs Product and Solutions
2.9.4 Mylan Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Mylan Recent Developments and Future Plans
2.10 Hikma Pharmaceuticals
2.10.1 Hikma Pharmaceuticals Details
2.10.2 Hikma Pharmaceuticals Major Business
2.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product and Solutions
2.10.4 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Hikma Pharmaceuticals Recent Developments and Future Plans
2.11 Sun Pharma
2.11.1 Sun Pharma Details
2.11.2 Sun Pharma Major Business
2.11.3 Sun Pharma Narcotic (Opioid) Drugs Product and Solutions
2.11.4 Sun Pharma Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Sun Pharma Recent Developments and Future Plans
2.12 Endo Pharmaceuticals
2.12.1 Endo Pharmaceuticals Details
2.12.2 Endo Pharmaceuticals Major Business
2.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Product and Solutions
2.12.4 Endo Pharmaceuticals Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Endo Pharmaceuticals Recent Developments and Future Plans
2.13 Allergan
2.13.1 Allergan Details
2.13.2 Allergan Major Business
2.13.3 Allergan Narcotic (Opioid) Drugs Product and Solutions
2.13.4 Allergan Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Allergan Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Narcotic (Opioid) Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Narcotic (Opioid) Drugs by Company Revenue
3.2.2 Top 3 Narcotic (Opioid) Drugs Players Market Share in 2022
3.2.3 Top 6 Narcotic (Opioid) Drugs Players Market Share in 2022
3.3 Narcotic (Opioid) Drugs Market: Overall Company Footprint Analysis
3.3.1 Narcotic (Opioid) Drugs Market: Region Footprint
3.3.2 Narcotic (Opioid) Drugs Market: Company Product Type Footprint
3.3.3 Narcotic (Opioid) Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Narcotic (Opioid) Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Narcotic (Opioid) Drugs Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Narcotic (Opioid) Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Narcotic (Opioid) Drugs Market Forecast by Application (2024-2029)
6 North America
6.1 North America Narcotic (Opioid) Drugs Consumption Value by Type (2018-2029)
6.2 North America Narcotic (Opioid) Drugs Consumption Value by Application (2018-2029)
6.3 North America Narcotic (Opioid) Drugs Market Size by Country
6.3.1 North America Narcotic (Opioid) Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Narcotic (Opioid) Drugs Consumption Value by Type (2018-2029)
7.2 Europe Narcotic (Opioid) Drugs Consumption Value by Application (2018-2029)
7.3 Europe Narcotic (Opioid) Drugs Market Size by Country
7.3.1 Europe Narcotic (Opioid) Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
7.3.3 France Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Narcotic (Opioid) Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Narcotic (Opioid) Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region
8.3.1 Asia-Pacific Narcotic (Opioid) Drugs Consumption Value by Region (2018-2029)
8.3.2 China Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
8.3.5 India Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
9 South America
9.1 South America Narcotic (Opioid) Drugs Consumption Value by Type (2018-2029)
9.2 South America Narcotic (Opioid) Drugs Consumption Value by Application (2018-2029)
9.3 South America Narcotic (Opioid) Drugs Market Size by Country
9.3.1 South America Narcotic (Opioid) Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Narcotic (Opioid) Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Narcotic (Opioid) Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country
10.3.1 Middle East & Africa Narcotic (Opioid) Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Narcotic (Opioid) Drugs Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Narcotic (Opioid) Drugs Market Drivers
11.2 Narcotic (Opioid) Drugs Market Restraints
11.3 Narcotic (Opioid) Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Narcotic (Opioid) Drugs Industry Chain
12.2 Narcotic (Opioid) Drugs Upstream Analysis
12.3 Narcotic (Opioid) Drugs Midstream Analysis
12.4 Narcotic (Opioid) Drugs Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Narcotic (Opioid) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Narcotic (Opioid) Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Narcotic (Opioid) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Narcotic (Opioid) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Pfizer Company Information, Head Office, and Major Competitors
Table 6. Pfizer Major Business
Table 7. Pfizer Narcotic (Opioid) Drugs Product and Solutions
Table 8. Pfizer Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Pfizer Recent Developments and Future Plans
Table 10. Teva Company Information, Head Office, and Major Competitors
Table 11. Teva Major Business
Table 12. Teva Narcotic (Opioid) Drugs Product and Solutions
Table 13. Teva Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Teva Recent Developments and Future Plans
Table 15. Purdue Pharma Company Information, Head Office, and Major Competitors
Table 16. Purdue Pharma Major Business
Table 17. Purdue Pharma Narcotic (Opioid) Drugs Product and Solutions
Table 18. Purdue Pharma Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Purdue Pharma Recent Developments and Future Plans
Table 20. Mallinckrodt Company Information, Head Office, and Major Competitors
Table 21. Mallinckrodt Major Business
Table 22. Mallinckrodt Narcotic (Opioid) Drugs Product and Solutions
Table 23. Mallinckrodt Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Mallinckrodt Recent Developments and Future Plans
Table 25. Amneal Pharma Company Information, Head Office, and Major Competitors
Table 26. Amneal Pharma Major Business
Table 27. Amneal Pharma Narcotic (Opioid) Drugs Product and Solutions
Table 28. Amneal Pharma Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Amneal Pharma Recent Developments and Future Plans
Table 30. Collegium Company Information, Head Office, and Major Competitors
Table 31. Collegium Major Business
Table 32. Collegium Narcotic (Opioid) Drugs Product and Solutions
Table 33. Collegium Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Collegium Recent Developments and Future Plans
Table 35. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 36. Johnson & Johnson Major Business
Table 37. Johnson & Johnson Narcotic (Opioid) Drugs Product and Solutions
Table 38. Johnson & Johnson Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Johnson & Johnson Recent Developments and Future Plans
Table 40. Merck Company Information, Head Office, and Major Competitors
Table 41. Merck Major Business
Table 42. Merck Narcotic (Opioid) Drugs Product and Solutions
Table 43. Merck Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Merck Recent Developments and Future Plans
Table 45. Mylan Company Information, Head Office, and Major Competitors
Table 46. Mylan Major Business
Table 47. Mylan Narcotic (Opioid) Drugs Product and Solutions
Table 48. Mylan Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Mylan Recent Developments and Future Plans
Table 50. Hikma Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 51. Hikma Pharmaceuticals Major Business
Table 52. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product and Solutions
Table 53. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Hikma Pharmaceuticals Recent Developments and Future Plans
Table 55. Sun Pharma Company Information, Head Office, and Major Competitors
Table 56. Sun Pharma Major Business
Table 57. Sun Pharma Narcotic (Opioid) Drugs Product and Solutions
Table 58. Sun Pharma Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Sun Pharma Recent Developments and Future Plans
Table 60. Endo Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 61. Endo Pharmaceuticals Major Business
Table 62. Endo Pharmaceuticals Narcotic (Opioid) Drugs Product and Solutions
Table 63. Endo Pharmaceuticals Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Endo Pharmaceuticals Recent Developments and Future Plans
Table 65. Allergan Company Information, Head Office, and Major Competitors
Table 66. Allergan Major Business
Table 67. Allergan Narcotic (Opioid) Drugs Product and Solutions
Table 68. Allergan Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Allergan Recent Developments and Future Plans
Table 70. Global Narcotic (Opioid) Drugs Revenue (USD Million) by Players (2018-2023)
Table 71. Global Narcotic (Opioid) Drugs Revenue Share by Players (2018-2023)
Table 72. Breakdown of Narcotic (Opioid) Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Narcotic (Opioid) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Narcotic (Opioid) Drugs Players
Table 75. Narcotic (Opioid) Drugs Market: Company Product Type Footprint
Table 76. Narcotic (Opioid) Drugs Market: Company Product Application Footprint
Table 77. Narcotic (Opioid) Drugs New Market Entrants and Barriers to Market Entry
Table 78. Narcotic (Opioid) Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Narcotic (Opioid) Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Narcotic (Opioid) Drugs Consumption Value Share by Type (2018-2023)
Table 81. Global Narcotic (Opioid) Drugs Consumption Value Forecast by Type (2024-2029)
Table 82. Global Narcotic (Opioid) Drugs Consumption Value by Application (2018-2023)
Table 83. Global Narcotic (Opioid) Drugs Consumption Value Forecast by Application (2024-2029)
Table 84. North America Narcotic (Opioid) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Narcotic (Opioid) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Narcotic (Opioid) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Narcotic (Opioid) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Narcotic (Opioid) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Narcotic (Opioid) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Narcotic (Opioid) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Narcotic (Opioid) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Narcotic (Opioid) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Narcotic (Opioid) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Narcotic (Opioid) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Narcotic (Opioid) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Narcotic (Opioid) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Narcotic (Opioid) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Narcotic (Opioid) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Narcotic (Opioid) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Narcotic (Opioid) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Narcotic (Opioid) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Narcotic (Opioid) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Narcotic (Opioid) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Narcotic (Opioid) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Narcotic (Opioid) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Narcotic (Opioid) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Narcotic (Opioid) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Narcotic (Opioid) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Narcotic (Opioid) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Narcotic (Opioid) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Narcotic (Opioid) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Narcotic (Opioid) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Narcotic (Opioid) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Narcotic (Opioid) Drugs Raw Material
Table 115. Key Suppliers of Narcotic (Opioid) Drugs Raw Materials
List of Figures
Figure 1. Narcotic (Opioid) Drugs Picture
Figure 2. Global Narcotic (Opioid) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Narcotic (Opioid) Drugs Consumption Value Market Share by Type in 2022
Figure 4. Codeine
Figure 5. Fentanyl
Figure 6. Hydrocodone
Figure 7. Hydromorphone
Figure 8. Meperidine
Figure 9. Methadone
Figure 10. Others
Figure 11. Global Narcotic (Opioid) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 12. Narcotic (Opioid) Drugs Consumption Value Market Share by Application in 2022
Figure 13. Pain Relief Application Picture
Figure 14. Anesthesia Application Picture
Figure 15. Global Narcotic (Opioid) Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Narcotic (Opioid) Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Narcotic (Opioid) Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Narcotic (Opioid) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Narcotic (Opioid) Drugs Consumption Value Market Share by Region in 2022
Figure 20. North America Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Narcotic (Opioid) Drugs Revenue Share by Players in 2022
Figure 26. Narcotic (Opioid) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Narcotic (Opioid) Drugs Market Share in 2022
Figure 28. Global Top 6 Players Narcotic (Opioid) Drugs Market Share in 2022
Figure 29. Global Narcotic (Opioid) Drugs Consumption Value Share by Type (2018-2023)
Figure 30. Global Narcotic (Opioid) Drugs Market Share Forecast by Type (2024-2029)
Figure 31. Global Narcotic (Opioid) Drugs Consumption Value Share by Application (2018-2023)
Figure 32. Global Narcotic (Opioid) Drugs Market Share Forecast by Application (2024-2029)
Figure 33. North America Narcotic (Opioid) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Narcotic (Opioid) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Narcotic (Opioid) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Narcotic (Opioid) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Narcotic (Opioid) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Narcotic (Opioid) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. France Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Narcotic (Opioid) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Narcotic (Opioid) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Narcotic (Opioid) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 50. China Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. India Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Narcotic (Opioid) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Narcotic (Opioid) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Narcotic (Opioid) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Narcotic (Opioid) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Narcotic (Opioid) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Narcotic (Opioid) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Narcotic (Opioid) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 67. Narcotic (Opioid) Drugs Market Drivers
Figure 68. Narcotic (Opioid) Drugs Market Restraints
Figure 69. Narcotic (Opioid) Drugs Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Narcotic (Opioid) Drugs in 2022
Figure 72. Manufacturing Process Analysis of Narcotic (Opioid) Drugs
Figure 73. Narcotic (Opioid) Drugs Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
